The PE Ratio as of December 2025 (TTM) for Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) is 21.06

According to Aspira Pathlab & Diagnostics Limited’s latest financial reports and current stock price. The company's current PE Ratio is 21.06. This represents a change of -32.47% compared to the average of 31.19 of the last 4 quarters.

Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) Historical PE Ratio (quarterly & annually)

How has ASPIRA.BO PE Ratio performed in the past?

The mean historical PE Ratio of Aspira Pathlab & Diagnostics Limited over the last ten years is -0.81. The current 21.06 PE Ratio has changed -260290.36% with respect to the historical average. Over the past ten years (40 quarters), ASPIRA.BO's PE Ratio was at its highest in in the September 2022 quarter at 707.22. The PE Ratio was at its lowest in in the December 2015 quarter at -170.16.

Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Aspira Pathlab & Diagnostics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) Average PE Ratio

How has ASPIRA.BO PE Ratio performed in the past?

The current PE Ratio of Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) PE Ratio vs. Peers

How is ASPIRA.BO’s PE Ratio compared to its peers?

Aspira Pathlab & Diagnostics Limited’s PE Ratio is less than Choksi Imaging Limited (22.70), greater than Biofil Chemicals and Pharmaceuticals Limited (19.69), greater than Vivo Bio Tech Limited (6.24), greater than Biofil Chemicals and Pharmaceuticals Limited (19.69), greater than Medinova Diagnostic Services Limited (19.99), less than Rajnish Wellness Limited (8.68K), greater than Vista Pharmaceuticals Limited (-7.76), greater than N G Industries Ltd. (8.83), greater than Vasundhara Rasayans Limited (15.50), greater than Godavari Drugs Limited (14.51),

Build a custom stock screener for Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aspira Pathlab & Diagnostics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aspira Pathlab & Diagnostics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.